Regulation of succinate-ubiquinone reductase and fumarate reductase activities in human complex II by phosphorylation of its flavoprotein subunit

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 85, Issue 7, 2009, Pages 258-265

  Tomitsuka, Eriko ^a   Kita, Kiyoshi ^b   Esumi, Hiroyasu ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Complex II; Fumarate; Phosphorylation; Respiratory chain; Succinate

Indexed keywords

FLAVOPROTEIN; GLUCOSE; PHOSPHATASE; PROTEIN KINASE; PROTEIN SUBUNIT; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE);

ANIMAL; ARTICLE; CELL HYPOXIA; CHEMISTRY; CULTURE TECHNIQUE; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; MITOCHONDRION; PHOSPHORYLATION; TUMOR CELL LINE;

ANIMALS; CELL CULTURE TECHNIQUES; CELL HYPOXIA; CELL LINE, TUMOR; ELECTRON TRANSPORT COMPLEX II; FLAVOPROTEINS; GLUCOSE; HUMANS; MITOCHONDRIA; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN SUBUNITS; SUCCINATE DEHYDROGENASE;

VERMES;

EID: 70350047282     PISSN: 03862208     EISSN: 13492896     Source Type: Journal    
DOI: 10.2183/pjab.85.258     Document Type: Article

References (33)

1. Favier, J., Briere, J.J., Strompf, L., Amar, L., Filali, M., Jeunemaitre, X. et al. (2005) Hereditary paraganglioma/ pheochromocytoma and inherited succinate dehydrogenase deficiency. Horm. Res. 63, 171-179.
2. Pawl, C., Bausch, B. and Neumann, H.P.H. (2005) Mutations of the SDHB and SDHD genes. Familial Cancer 4, 49-54.
3. Muller, U., Troidl, C. and Niemann, S. (2005) SDHC mutations in hereditary paraganglioma/pheochromocytoma. Familial Cancer 4, 9-12.
4. Tomitsuka, E., Goto, Y., Taniwaki, M. and Kita, K. (2003) Direct evidence for expression of Type II flavoprotein subunit in human complex II (succinate-ubiquinone reductase). Biochem. Biophys. Res. Com. 311, 774-779.
5. Tomitsuka, E., Hirawake, H., Goto, Y., Taniwaki, M., Harada, S. and Kita, K. (2003) Direct evidence for two distinct forms of the flavoprotein subunit of human mitochondrial complex II (succinate-ubiquinone reductase). J. Biochem. 134, 191-195.
6. Warburg, O. (1956) On respiratory impairment in cancer cells. Science 124, 269-270.
7. Semenza, G.L. (2007) HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J. Bioenerg. Biomembr. 39, 231-234.
8. Brown, J.M. and Wilson, W.R. (2004) Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer 4, 437-447.
9. Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H. et al. (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 69, 4918-4925.
10. Kita, K., Hirawake, H., Miyadera, H., Amino, H. and Takeo, S. (2002) Role of complex II in anaerobic respiration of the parasite mitochondria from Ascaris suum and Plasmodium falciparum. Biochim. Biophys. Acta 1553, 123-139.
11. Miyadera, H., Hiraishi, A., Miyoshi, H., Samamoto, K., Mineki, R., Murayama, K. et al. (2003) Complex II from phototrophic purple bacterium Rhofoferax fermentans displays rhodoquinol-fumarate reductase activity. Eur. J. Biochem. 270, 1863-1874.
12. Weinberg, J.M., Venkatachalam, M.A., Roeser, N.F. and Nissim, I. (2000) Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediate. Proc. Natl. Acad. Sci. USA 97, 2826- 2831.
13. Selak, M.A., Armour, S.M., MacKenzie, E.D., Boulahbel, H., Watson, D.G., Mansfield, K.D. et al. (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-a prolyl hydroxylase. Cancer Cell 7, 77-85.
14. Henrich, H., Paddenberg, R., Haberberger, R.V., Scholz, A., Gruss, M., Hempelmann, G. et al. (2004) Hypoxic increase in nitric oxide generation of rat sensory neurons requires activation of mitochondrial complex II and voltage-gated calcium channels. Neuroscience 128, 337-345.
15. Pollard, P.J., Briere, J.J., Barwell, J., Barclay, E., Wortham, N.C., Hunt, T. et al. (2005) Accumulation of Krebs cycle intermediates and overexpression of HIF1a in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14, 2231-2239.
16. Hagerhall, C. (1997) Succinate: quinone oxidoreductases. Variations on a conserved theme. Biochim. Biophys. Acta 1320, 107-141.
17. Papa, S., Sardanelli, A.M., Scacco. S., Petruzzella, V., Technikova-Dobrova, Z., Vergari, R. et al. (2002) The NADH: ubiquinone oxidoredactase (Complex I) of the mammalian respiratory chain and the cAMP cascade. J. Bioenerg. Biomembr. 34, 1-10.
18. Papa, S., Scacco. S., Sardanelli, A.M., Petruzzella, V., Vergari, R., Signorile, A. et al. (2002) Complex I and the cAMP cascade in human physiopathology. Biosci. Rep. 22, 3-15.
19. Schulenberg, B., Aggeler, R., Beechem, J.M., Capaldi, R.A. and Patton, W.F. (2003) Analysis of steady-state protein phosphorylation in mitochondria using novel fluorescent phosphosensor dye. J. Biol. Chem. 278, 27251-27255.
20. Murray, J., Marusich, M.F., Capaldi, R.A. and Aggeler, R. (2004) Focused proteomics: monoclonal antibody-based isolation of the oxidative phosphorylation machinery and detection of phosphoproteins using a fluorescent phosphoprotein gel stain. Electrophoresis 25, 2520-2525.
21. Hopper, R., Carroll, S., Aponte, A.M., Johnson, D.T., French, S., Shen, R.-F. et al. (2006) Mitochondrial matrix phosphoproteome: effect of extra mitochondrial calcium. Biochemistry 45, 2524-2536.
22. Salvi, M., Morrice, N.A., Brunati, A.M. and Toninello, A. (2007) Identification of the flavoprotein ofsuccinate dehydrogenase and aconitase as in vitro mitochondrial substrates of Fgr tyrosine kinase. FEBS Lett. 581, 5579-5585.
23. Kler, R.S., Jackson, S., Bartlett, K., Bindoff, L.A., Eaton, S., Pourfarzan, M. et al. (1991) Quantitation of Acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondria fatty acid oxidation. J. Biol. Chem. 266, 22932-22938.
24. Sardanelli, A.M., Technikova-Dobrova, Z., Scacco, S.C., Speranza, F. and Papa, S. (1995) Characterization of proteins phosphorylated by the cAMPdependent protein kinase of bovine heart mitochondria. FEBS Lett. 377, 470-474.
25. 556, J. Biol. Chem. 264, 2672-2677.
26. Lee, I., Bender, E. and Kadenbach, B. (2002) Control of mitochondrial membrane potential and ROS formation by reversible phosphorylation of cytochrome c oxidase. Mol. Cell Biochem. 234/235, 63-70.
27. Shaw, R.J. and Cantley, L.C. (2006) Ras, PI(3)K and mTOR signaling controls tumor cell growth. Nature 441, 424-431.
28. Izuishi, K., Kato, K., Ogura, T., Kinoshita, T. and Esumi, H. (2000) Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. Cancer Res. 60, 6201-6207.
29. Esumi, H., Izuishi, K., Kato, K., Hashimoto, K., Kurashima, Y., Kishimoto, A. et al. (2002) Hypoxia and nitric oxide treatment confer tolerance to glucose starvation in a 5'-AMP-activared protein kinase-dependent manner. J. Biol. Chem. 277, 32791-32798.
30. Elstrom, R.L., Bauer, D.E., Buzzai, M., Karnauskas, R., Harris, M.H., Plas, D.R. et al. (2004) Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 64, 3892-3899.
31. Robey, R.B. and Hay, N. (2005) Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 25, 4683-4696.
32. Guertin, D.A. and Sabatini, D.M. (2007) Defining the role of mTOR in cancer. Cancer Cell 12, 9-22.
33. Seeliger, H., Guba, M., Kleespies, A., Jauch, K.-W. and Bruns, C.J. (2007) Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastasis, and angiogenesis. Cancer Metast. Rev. 26, 611-621.